Clene (CLNN) had the highest return in 2018 by a US stock in the Nasdaq Composite (IXIC), returning 16,499,900%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Clene (CLNN) | 2018 | 16,499,900% |
Immatics (IMTX) | 2018 | 195,900% |
Reliance Global (RELI) | 2018 | 6,900% |
Kaival Brands Innovations (KAVL) | 2018 | 4,300% |
American Resources Corp Class A (AREC) | 2018 | 1,861.17% |
Tandem Diabetes Care (TNDM) | 2018 | 1,515.74% |
Nuzee (NUZE) | 2018 | 1,061.54% |
Ryvyl (RVYL) | 2018 | 1,033.33% |
Nocera (NCRA) | 2018 | 700% |
Turtle Beach (HEAR) | 2018 | 679.27% |
Lixte Biotechnology (LIXT) | 2018 | 467.38% |
Nutriband (NTRB) | 2018 | 411.98% |
Focus Universal (FCUV) | 2018 | 393.33% |
AGM Group Holdings Inc Class A (AGMH) | 2018 | 386.36% |
ProQR Therapeutics (PRQR) | 2018 | 385.54% |
Paysign (PAYS) | 2018 | 375.68% |
Semler Scientific (SMLR) | 2018 | 358.67% |
Flux Power (FLUX) | 2018 | 337.5% |
Xpel (XPEL) | 2018 | 326.68% |
Novo Integrated Sciences (NVOS) | 2018 | 292.93% |
Quantum Computing (QUBT) | 2018 | 275% |
Caredx (CDNA) | 2018 | 240.19% |
Amarin (AMRN) | 2018 | 239.4% |
Arrowhead Pharmaceuticals (ARWR) | 2018 | 236.59% |
Harrow Health (HROW) | 2018 | 234.71% |
